4 IGG ANTIISLET HUMAN MONOCLONAL-ANTIBODIES ISOLATED FROM A TYPE-1 DIABETES PATIENT RECOGNIZE DISTINCT EPITOPES OF GLUTAMIC-ACID DECARBOXYLASE-65 AND ARE SOMATICALLY MUTATED
Am. Madec et al., 4 IGG ANTIISLET HUMAN MONOCLONAL-ANTIBODIES ISOLATED FROM A TYPE-1 DIABETES PATIENT RECOGNIZE DISTINCT EPITOPES OF GLUTAMIC-ACID DECARBOXYLASE-65 AND ARE SOMATICALLY MUTATED, The Journal of immunology, 156(9), 1996, pp. 3541-3549
The selective destruction by an autoimmune process of the beta cells i
n the pancreas is the hallmark of the type 1 insulin-dependent diabete
s mellitus. What triggers islet cell-specific autoreactive T and B cel
ls, however, remains unclear. Identification of the targets of the ant
i-islet cell autoantibodies frequently found in insulin-dependent diab
etes mellitus patients and analysis of their sequences should provide
some insights into the nature of this disease. We have combined EBV tr
ansformation with CD40 activation of peripheral B cells from one patie
nt with insulin-dependent diabetes mellitus to isolate four B cell clo
nes that secrete islet cell-specific autoantibodies. These four human
monoclonal autoantibodies are of the IgG1 isotype, and they each recog
nize a different epitope of the glutamic acid decarboxylase enzyme. An
alysis of their variable gene sequences shows that, while clonally unr
elated, three of the four human monoclonal autoantibodies use a member
of the V(H)4 family, and two have rearranged the same lambda light ch
ain variable gene. The IgG1 isotype of the four autoantibodies as well
as the presence of somatic mutations in both heavy and light drain ge
nes provide concrete evidence for their derivation by a T cell-depende
nt immune response.